A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4 + and CD8 + T Cells in COVID-19 Patients

Henning Zelba1, David Worbs2, Johannes Harter2, Natalia Pieper2, Christina Kyzirakos-Feger3, Simone Kayser3, Marcel Seibold3, Oliver Bartsch3, Jiri Ködding2, Saskia Biskup3
  1. CeGaT GmbH, 72076 Tübingen, Germany; and henning.zelba@cegat.de.
  2. CeGaT GmbH, 72076 Tübingen, Germany; and.
  3. Praxis fuer Humangenetik, 72076 Tübingen, Germany.